In Brief
CSP is the target of protective antibodies against the malaria parasite Plasmodium falciparum (Pf). Here, Triller and Scally et al. identified potent Pf-inhibitory human anti-CSP memory B cell antibodies induced by natural exposure and unveiled the molecular details of antigen binding to two protective CSP repeat epitopes.
SUMMARY
Antibodies against the NANP repeat of circumsporozoite protein (CSP), the major surface antigen of Plasmodium falciparum (Pf) sporozoites, can protect from malaria in animal models but protective humoral immunity is difficult to induce in humans. Here we cloned and characterized rare affinity-matured human NANP-reactive memory B cell antibodies elicited by natural Pf exposure that potently inhibited parasite transmission and development in vivo. We unveiled the molecular details of antibody binding to two distinct protective epitopes within the NANP repeat. NANP repeat recognition was largely mediated by germline encoded and immunoglobulin (Ig) heavy-chain complementarity determining region 3 (HCDR3) residues, whereas affinity maturation contributed predominantly to stabilizing the antigen-binding site conformation. Combined, our findings illustrate the power of exploring human anti-CSP antibody responses to develop tools for malaria control in the mammalian and the mosquito vector and provide a molecular basis for the structure-based design of next-generation CSP malaria vaccines.
INTRODUCTION
Plasmodium falciparum (Pf) is a protozoan parasite with a complex life cycle that causes malaria, a severe and potentially fatal disease. Pf is transmitted to humans by infected female Anopheles mosquitoes, which inject small numbers of sporozoites into the skin during their blood meals. The infection is established within hours after the injected sporozoites migrate to the liver and invade hepatocytes. Upon further development, blood stage parasites are released from the infected hepatocytes and undergo successive rounds of multiplication in erythrocytes. The increase in blood stage parasitaemia causes disease symptoms and may lead to life-threatening complications without treatment. In endemic areas, immunity to Pf develops slowly after repeated infections but is rarely sterile (Bousema et al., 2014; Doolan et al., 2009; Langhorne et al., 2008; Struik and Riley, 2004 ). Therefore, a major goal in vaccine development remains to induce sterilizing immunity through anti-sporozoite antibodies and T cell responses. The target antigen of the most advanced Pf malaria subunit vaccine RTS,S is circumsporozoite protein (CSP), the major sporozoite surface protein (Aikawa et al., 1981; Cohen et al., 2010; Yoshida et al., 1980) . Pf CSP consists of an N-terminal domain, a central region consisting predominantly of NANP repeats, which differs in length between individual Pf strains, and a C-terminal domain. CSP plays a critical role in the Plasmodium life cycle and is essential for parasite development in the mosquito vector and the mammalian host (Cerami et al., 1992; Frevert et al., 1993; Mé nard et al., 1997; Sidjanski et al., 1997) .
The B cell response to CSP targets predominantly the central NANP region. Antibodies against the NANP repeat can protect from Plasmodium infection in animal models and anti-CSP titers are associated with protection after RTS,S immunization (Foquet et al., 2014; RTS,S Clinical Trials Partnership, 2015; Sumitani et al., 2013; White et al., 2013) . However, RTS,S shows relatively low and short-lived efficacy, and serum antibody titers wane quickly in the absence of repeated natural Pf exposure suggesting that protective B cell memory against CSP may not form efficiently (Crompton et al., 2014; Langhorne et al., 2008; Offeddu et al., 2012; Portugal et al., 2013; Struik and Riley, 2004) . A deeper understanding of the molecular and functional characteristics of human memory B cell antibodies can provide important insights into the development of protective antibody responses and facilitate the rational design of novel vaccination strategies as demonstrated for other pathogens (e.g. RSV [Boyington et al., 2013] , HIV [Briney et al., 2016; Escolano et al., 2016; de Taeye et al., 2015; Tian et al., 2016] ). Here, we used single-cell antibody cloning to determine the frequency and quality of human anti-CSP memory B cell antibodies that developed in response to natural Pf exposure and defined the structural basis of antigen recognition that underlies parasite inhibition.
RESULTS

Weak anti-CSP Memory B Cell Responses Develop after Long-Term Natural Pf Exposure
To identify and isolate CSP-reactive memory B cells, we collected blood samples for the isolation of mononuclear cells from 80 healthy adults living in the malaria-endemic area of Lambaré né , Gabon ( Figure 1A ). Although the time-point of the last infection was unknown, we assume that all of these donors had a history of repeated Pf exposure. African donors showed higher frequencies of total memory B cells compared to Pf non-exposed European donors, likely reflecting differences in the overall immune status and degree of exposure to pathogens (mean = 31.2 ± SD = 15.1 and mean = 11.8 ± SD = 1.6, respectively, Figure 1A ). Using fluorescently-labelled CSP and MSP3, a representative blood stage antigen, we determined the frequency of CSP-and MSP3-reactive memory B cells in flow cytometric analyses. We defined memory B cells as CSP- Figure S1A ). In the absence of acute Pf exposure and high frequencies of circulating plasmablasts, a small fraction of these cells might express the plasmablast marker CD38 (Keitany et al., 2016) . CSP-reactive memory B cells above background (European donors with no history of Pf exposure) were detected in 77/80 African donors albeit at relatively low frequency (mean = 0.15 ± SD = 0.1, range 0.03%-0.56%, Figure 1B ) compared to the frequency of memory B cells against MSP3 (mean = 0.9 ± 0.57, range = 0.2% -2.8%. Muellenbeck et al., 2013) . Overall weak anti-CSP responses compared to MSP3 were also observed at serum antibody level ( Figures 1C and 1D ). Only 45% and 4% of donors exhibited circulating IgG and IgM anti-CSP antibodies, respectively, independent of the frequency of anti-CSP memory B cells ( Figures 1E and 1F ).
To determine the molecular features of anti-CSP memory B cell antibodies induced by natural Pf exposure, we selected four donors with high (donors 71, 29) or intermediate (donors 40, 16) anti-CSP serum titers for the flow cytometric isolation of single CSP-reactive memory B cells and subsequent Ig gene amplification and sequencing (Figures 1G and 1H and S1A) . When used in immunofluorescence assays (IFA), only sera from donors with high anti-CSP serum titers showed strong IgG sporozoite reactivity ( Figure 1I ). Ig gene sequence analysis determined that on average almost 30% of the CSP-reactive memory B cells were IgM (range 11%-63%). As expected, these antibodies had been cloned exclusively from cells that lacked surface IgG expression demonstrating the validity of our gating strategy and assumption that CSP-reactive IgG À memory B cells are non-switched IgM expressing cells. Overall, IgG was the most prominent isotype detected in three donors with a strong contribution of IgG1 and IgG3, typically enriched in anti-CSP responses, whereas IgM was dominant only in donor 29 (Figures 1J and S1B) (Ikpa and Adebambo, 2011; John et al., 2008; Krishnamurty et al., 2016; Noland et al., 2015) . Independent of the isotype, the vast majority of IGH, IGK, and IGL genes were somatically mutated indicating that the response in all donors involved IgG + as well as IgM + memory B cells (Figures 1K and S1C) . This is in line with a recently reported role for IgM + memory B cells in P. chabaudi infection in a rodent model (Krishnamurty et al., 2016) . Shared somatic hypermutations (SHM) in different antibody genes from individual donors indicated that these cells (legend continued on next page) had originated from a common ancestor cell and underwent clonal expansion and substantial diversification presumably during germinal center reactions. Such clonally related cell clusters of different sizes were identified in all donors and varied in their degree of mutational diversity among the members ( Figures  S1D and S1E) . In donor 71, clonally related cells from 6/13 clusters were also isolated from a blood sample two years later, demonstrating that the clusters were stable over this time (Table  S1 ). All of these clusters had undergone class-switching to IgG1, IgG2, or IgG3 subtypes, and the largest cluster comprised IgG1 and IgG3 cells. Thus, natural Pf exposure induces weak anti-CSP serum and memory B cell responses but individual IgG memory B cell clones persist and diversify over years.
Anti-CSP Memory B Cell Antibodies Recognize the Central NANP Repeat and Inhibit Sporozoite Traversal of Hepatocytes
To assess the quality of the anti-CSP response, we cloned and expressed the Ig genes of 208 memory B cells from the four selected donors and measured the reactivity of the recombinant monoclonal antibodies by enzyme-linked immunosorbent assay (ELISA). Only 27 antibodies showed detectable CSP-ELISA and whole sporozoite IFA reactivity at the concentrations tested (Figures 2A and 2B) . These antibodies, cloned exclusively from the donors with the highest anti-CSP serum titers, carried substantial numbers of somatic mutations, and were either IgM or class-switched (Table S2) . With one exception, these antibodies were CSP-specific and lacked cross-reactivity with unrelated antigens ( Figure S1F and Table S2 ). The majority of antibodies recognized the NANP repeat, a well-known B cell epitope and target of protective antibodies ( Figure 2C ) (Dups et al., 2014) . The repetitive nature of this region in the full-length CSP might have contributed to the avidity-based isolation of memory B cells expressing antibodies with low or undetectable CSP-ELISA and IFA reactivity. This biological interpretation is supported by the results of an independent study of a controlled human malaria infection trial using the same CSP-based isolation strategy. In this study, only few monoclonal antibodies with high CSP-ELISA reactivity were cloned from memory B cells obtained after only one Pf infection, whereas the majority lacked detectable CSP-ELISA reactivity. However, after a second or third Pf infection the majority of cloned antibodies were CSP-ELISA reactive and only a few showed no detectable CSP-reactivity in ELISA (Murugan et al., G.T., C.K., G.C., E. A.L., B.M., and H.W., unpublished). We next examined the inhibitory activity of the cloned antibodies. With one exception, all (26/27) Pf CSP-reactive antibodies inhibited sporozoite traversal of hepatocytes in vitro ( Figure 2D and Table S2 ). The degree of inhibition correlated with the NANP repeat ELISA reactivity and was similar for closely related antibodies within individual clusters ( Figure 2E ). Thus, antibodies derived from anti-CSP memory B cells induced by natural parasite exposure recognize predominantly the NANP repeat and block hepatocyte traversal of Pf sporozoites in vitro.
Anti-CSP Memory B Cell Antibodies Block Hepatocyte Infection To determine whether the anti-CSP antibodies also inhibited hepatocyte infection and subsequent sporozoite development into exoerythrocytic forms (EEF), we generated a chimeric line (Pb-PfCSP) of the rodent P. berghei (Pb) parasite in which the endogenous Pb CSP gene was replaced with the full-length Pf CSP gene by homologous recombination ( Figure S2 ). Pb-PfCSP developed equal sporozoite numbers in infected mosquitoes compared to the parental Pb line and showed similar in vitro infectivity based on EEF development in hepatocyte lines and in vivo infectivity in wild-type mice ( Figures S2F-S2H (Table S2) , showed the highest inhibitory activity ( Figure S3A ). These findings validate the use of the chimeric Pb line to assess the infection blocking activity of our antibodies and identified the most potent antibodies for further functional analyses.
NANP-Reactive Memory B Cell Antibodies Inhibit Malaria Transmission and Protect from Malaria Infection
We tested whether exposure of sporozoites to anti-CSP antibodies prior to transmission from the mosquito to the mammalian host might impair sporozoite infectivity (Sumitani et al., 2013; Yoshida and Watanabe, 2006) . For this purpose, we generated a transgenic Anopheles coluzzii mosquito line (Aapp::125) expressing a FLAG-tagged single-chain Fv fragment of antibody 125 in their salivary glands and infected them with Pb-PfCSP ( Figures S3B-S3D ) (Sumitani et al., 2013; Yoshida and Watanabe, 2006) . Pb-PfCSP sporozoites were isolated at normal numbers from the salivary glands of single-chain Fv-expressing Aapp::125 compared to wild-type mosquitoes but were impaired in their development into EEF in vitro (Figure S3E) . To test whether the antibody fragment could also block transmission in vivo, we allowed Pb-PfCSP-infected Aapp::125 and Pb-PfCSP-infected wild-type mosquitoes to blood-feed on Table S2. healthy mice. Blood stage parasites were detected in only 10% of mice exposed to bites from infected Aapp::125 mosquitoes, whereas 80% of mice exposed to infectious bites of wild-type mosquitoes developed parasitaemia ( Figure 3A) . Notably, the single mouse infected by bites of Aapp::125 mosquitoes showed a 2-day delay in the development of blood-stage parasites suggesting a substantial reduction in liver infection ( Figure 3B ). Thus, expression of an anti-CSP single-chain Fv in the mosquito salivary glands efficiently blocked parasite transmission to the mammalian host and strongly inhibited parasite development in the single case when protection was not complete.
To determine whether the antibodies would also protect mice from Plasmodium infection after passive immunization, we administered antibody 663, the clonal relative of 125 with slightly better performance in the in vitro assays, and antibody 580 intraperitoneally (i.p.) one day prior to infection by subcutaneous (s.c.) injection of Pb-PfCSP sporozoites ( Figures 3C and 3D ). Passive immunization protected the majority of mice (91% and 72% for 663 and 580, respectively) from the development of blood stage parasites ( Figure 3C ). The few animals in which the antibodies did not fully control the infection, developed blood stage parasitemia with a 2-day delay compared to control mice ( Figure 3D ).
To further validate our findings in vivo, we extended our analyses to the humanized FRG-huHep mouse model, which supports the development of Pf liver stages and is used to determine antibody-mediated inhibition of liver infection by bioluminescence after infection with a transgenic Pf parasite expressing GFP and luciferase (Sack et al., 2017; Vaughan et al., 2012a Vaughan et al., , 2012b . Passive immunization with antibody 125, 663, or 580 one day before exposure to the bites of infected mosquitoes strongly reduced parasite burden at the peak of liver infection compared to control FRG-huHep mice ( Figure 3E ).
In summary, antibodies 125, 663, and 580 protected the majority of mice from Plasmodium infection and substantially reduced hepatocyte infection and/or sporozoite development in the few non-protected animals after passive immunization or if expressed as single-chain Fv in the mosquito salivary gland. Thus, the NANP-repeat-specific memory B cell antibodies are potent inhibitors of malaria transmission and protect from parasite infection.
Pf-Inhibitory Antibodies Recognize Two Distinct NANP Conformations
To establish how the antibodies recognized the NANP repeat, we structurally characterized 580-and 663-Fabs and their predicted germline ancestors (580-g and 663-g). Co-crystal structures of antibody with a NANP 5 repeat peptide could be determined for the 580-g-Fab and the 663-Fab to 1.6 Å and 3.15 Å resolution, respectively ( Figure 4 and Table S3 ). We observed strong electron density for at least seven of 20 Pf NANP 5 repeat peptide residues in each structure, indicating that both antibodies bind to a conserved core repeat ( Figures S4A and S4B ).
The antibodies show major differences in their antigen-binding mode and recognize distinct conformations of the NANP 5 peptide. 580-g binds to an elongated conformation of the NANP 5 peptide using a shallow interface between the light (L)-and heavy (H)-chain ( Figures 4A-4C ). Four of the six 580-g complementary determining regions (CDRs) contact the peptide (with HCDR1 and HCDR2 contributing no interactions), culminating in 522 Å 2 of buried surface area (Table S4 ). Interactions are dominated by the HCDR3, centering on Arg100E that is stabilized by (E) Bioluminescence analysis of FRG-huHep mice challenged with bites from 50 PfGFP-luc sporozoites-infected mosquitoes after passive immunization with the indicated antibodies (580, n = 5; 663, n = 5; 125, n = 5; negative control, n = 10 individual mice; circle, one mouse; bar, mean ± SEM). Parasite burden was determined after normalization to the mGO53 control group. 1-way ANOVA with Kruskal-Wallis **p < 0.001, F(4, 25) = 6.456. Data in (A) and (B) are from three independent experiments and were analyzed using Log-rank Mantel-Cox test, ****p < 0.0001. See also Figure S3 .
contacts to several residues of NANP 5 ( Figure 4C and Table S4 ). Additionally, germline-encoded LCDR1 and LCDR3 Tyr residues L-27D, L-32, and L-92 stabilize binding through an aromatic cage around Pro8 ( Figure 4C ). In contrast, 663 binds the NANP 5 peptide in a turn conformation via a deep cleft created by a radially oriented HCDR3 . All six 663 CDRs contribute to recognition of the peptide with a total of 582 Å 2 of buried surface area and the central NPNA hydrogen-bonds exclusively to main-chain atoms ( Figure 4F and Table S5 ). The 663-bound peptide adopts a type I b-turn ( Figure 5A and Table S6 ) in strong agreement with the previously determined crystal structure of an ANPNA peptide (superposing well over the NPNA cadence with an r.m.s.d. of 0.40 Å ) (Ghasparian et al., 2006) . In contrast, the 580-g-bound peptide adopts an elongated conformation ( Figure 5B and Table S6 ) that forms an asx type II turn (with a r.m.s.d. of 0.29 Å over the NPNA cadence of the previously described NPNA crystal structure). Our peptide crystal structures are consistent with previous studies that have shown dynamic equilibrium between elongated and type I b-turn conformations with NANP peptides (Dyson et al., 1990).
Crystal packing positions two 663-Fab paratopes facing one another, with the C-terminus of one peptide and the N-terminus of the symmetry-related peptide separated by 11.8 Å (Figure S4C ). Thus, it is conceivable that two 663-Fabs bind one NANP 5 peptide in our structure (Fisher et al., 2017) . 663-Fab displayed a 10-fold higher affinity to CSP as compared to 580-Fab, with a much slower off-rate (Table S7) , which is consistent with the more extensive antibody-antigen interactions observed in our co-crystal structure (Figures 4C and 4F, Tables S4 and S5) .
To investigate the overall topology of 580 and 663 binding to full-length CSP, we performed size-exclusion chromatography small-angle X-ray scattering experiments (SEC-SAXS) on 580-and 663-Fab co-complexes with CSP from the 7G8 strain, which in contrast to NF54 contains only five NANP repeats. Co-complexes were incubated in a near stoichiometric molar ratio of antibody to CSP, prior to SEC-SAXS. 580-and 663-Fab CSP co-complexes ( Figure S5 ) revealed that recognition of different core epitope conformations is also associated with binding in slightly different orientations ( Figure 5C ). Figure S4 and Tables S3-S5. Combined, our X-ray crystallography and SAXS studies show that the Pf inhibitory antibodies target two distinct CSP NANPrepeat configurations.
Somatic Mutations Stabilize the Conformation of the Paratopes
Next we explored the role of somatic mutations in generating potent NANP binders in response to natural parasite exposure. Antibodies 580 and 663 underwent a total of 39 and 58 SHM at nucleotide level, resulting in 27 and 32 amino acid exchanges, respectively ( Figure S6 ). Expectedly, mutated 580 and 663 antibodies each bound with approximately 15-20-and 140-260-fold higher affinity to both the NANP 5 peptide and the recombinant CSP than their unmutated 580-g and 663-g counterparts, respectively (Figures 6A-6D and Table  S7 ). Although CSP binding and Pf inhibition was reduced, it was not completely abrogated, indicating that germline-encoded residues play an important role in CSP binding (Figures  6E-6H and Table S7 ).
Indeed, analysis of unliganded 580-Fab and 663-g-Fab crystal structures revealed that mutated residues rarely generate additional contacts to the core Pf CSP epitope (Figures 7A and 7B) . In 580, only a L-Lys30 to L-Arg30 mutation presumably leads to new contacts with the Pro4 carbonyl of the NANP epitope ( Figure 7C ). Core epitope recognition of the mutated antibodies is largely mediated by germlineencoded amino acids and HCDR3, whereas most affinitymatured residues do not contact the core peptide, raising the possibility of an expanded epitope in the context of full-length CSP ( Figures 7A and 7B ). Several mutations in 580 ( Figure 7D ) and 663 ( Figures 7E and 7F ) lead to stabilization of CDR conformations, rigidifying the antigen binding site while preserving a similar surface electrostatic potential (Figures S7A-S7D) . Accordingly, the 663 unliganded structure reveals high conformational similarity in its CDRs compared to the NANP 5 -bound structure, further supporting stabilization Figure S5 and Tables S6 and S7. of the paratope as a means for improved NANP-repeat recognition and parasite inhibition ( Figure S7E ).
We conclude that core epitope recognition of the mutated antibodies is largely mediated by germline-encoded amino acids and HCDR3, whereas most affinity-matured residues do not contact the core peptide and instead stabilize the conformation of the antigen-binding site.
DISCUSSION
Humoral immunity to natural Pf exposure is typically short-lived and non-sterilizing, suggesting that protective B cell memory against sporozoite antigens, including CSP, is formed inefficiently. However, the potency of anti-CSP memory B cell antibodies has never been measured. Here we have shown that natural parasite exposure generated anti-CSP memory B cells that expressed Pf inhibitory antibodies suggesting that the overall strength of the response rather than the quality of CSP memory B cell antibodies might be insufficient to mediate long-lasting protection. The small number of parasites that were injected locally into the skin during natural Pf infection likely induced only weak anti-CSP immune responses that were further suppressed by the strong immune responses elicited by the high load of systemic antigen from asexual blood stage parasites (Foquet et al., 2014; Keitany et al., 2016; Scholzen and Sauerwein, 2013) . Further, we have provided evidence that clonally expanded cell clusters expressing potent anti-NANP repeat antibodies could persist in the same donor over years demonstrating that the induction of high-quality and stable memory B cells is rare but possible. However, memory B cells protect from infection only indirectly upon antigen-mediated reactivation and differentiation into antibody secreting cells. This process takes several days, whereas liver cell infection is established within hours after sporozoite inoculation. Thus, the complexity of the parasite life cycle rather than the inability of the human immune system to induce memory B cells expressing protective antibodies against CSP may be associated with the lack of sterilizing immunity ( The antibodies identified here efficiently prevented malaria infection by inhibiting Plasmodium transmission from the mosquito vector to the mammalian host. During sporozoite development in the mosquito, CSP is expressed already before the invasion of salivary glands, offering an opportunity to exploit human antibodies for the development of safe and efficient vector-based transmission-blocking strategies (Sumitani et al., 2013) . Because CSP is essential for sporozoite development and invasion of the salivary glands, it seems unlikely that the parasite would find mechanisms to evade antibody targeting. Further, efficient blocking of parasite infection in a series of animal models used in this study suggests that the antibodies could play an important role in mediating protection from Pf infection in humans. We found that antibody 580 was overall less efficacious than antibody 663 in all assays, although the differences were not significant. Future experiments will have to corroborate these findings to determine whether differences in the antigen-binding mode or affinity might correlate with efficacy. Nevertheless, our data demonstrate the power of mining the human anti-CSP antibody repertoire for better understanding of the complexity of antibody-CSP interactions and to identify molecular correlates of protection.
We found that the antibodies used primarily germline-encoded regions and the HCDR3 for recognition of the core NANP repeat suggesting that the naïve human B cell repertoire possesses the pre-requisites for effective interactions with the CSP repeat independently of excessive somatic hypermutation. Somatic hypermutations predominantly led to the stabilization of the antigen-binding site, a relatively common strategy of antibodies to improve affinity, but did not engage into direct interactions with the core epitope (Wedemayer et al., 1997) . In line with these findings, repeated whole sporozoite immunizations in controlled human malaria infection of malaria naïve volunteers under chemoprophylaxis showed that protective memory B cell responses against the NANP repeat are more likely to evolve from potent germline precursors than by affinity maturation to the core epitope (Murugan et al., G.T., C.K., G.C., E. A.L., B.M., and H.W., unpublished data). Therefore, our data support vaccination strategies that seek to activate strong germline responses against the CSP repeat with immunogens designed using structureguided approaches, similar to strategies being explored against other pathogens (Ekiert et al., 2009; Jardine et al., 2013) . Taken together, our findings illustrate the power of exploring human anti-CSP antibody responses to develop tools for malaria control not only in the mammalian host but also in the mosquito vector. Future studies should assess the impact immunogens with different NANP conformations have on the quality of anti-CSP B cell responses as a basis for the development of next-generation CSP vaccines. Table S7 .
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 1947-1957. of Helsinki. Volunteers who provided written informed consent following information about the study were screened. Inclusion criteria were: age >18 years, hemoglobin concentration >10g/dl, negative thick blood smear (Planche et al., 2001) and no acute symptoms of disease. Exclusion criteria were: pregnancy, chronic infection, autoimmune disease, previous participation in a malaria vaccine trial, cancer and immunosuppressive therapy. In addition, samples collected in July-August 2010 during the Bmem2010 study were used (Muellenbeck et al., 2013) . Some of the study participants of the Bmem2010 study, including donor 71, were re-sampled during the dry-season of 2012.
Cell Lines
Human embryonic kidney HEK 293 T cells were cultured according to the manufacturer's instructions. The cells were grown at 37 C and 8% CO 2 . The hepatocyte cell line HC04 (Sattabongkot et al., 2006) was cultured at 37 C and 5% CO 2 using HC04 complete culture medium. This comprises of 428.75 ml MEM (-L-glu), 428.75 ml F-12 Nutrient Mix (+ L-glu), 15 mM HEPES, 1.5 g/l NaHCO3, 2.5 mM L-glutamine and 10% FCS. See ''Key Resources Table' ' for details. Cell lines have not been authenticated.
Bacteria
MAX Efficiency
Ò DH10BÔ Competent Cells were grown in LB medium for cultivation and in Terrific Broth for plasmid purification.
Bacterial shaker at 37 C and 180 rpm was used for cultivation.
Pf Parasites Pf NF54 (a kind gift of Dr. R. Sauerwein) and PfGFP-luc (Vaughan et al., 2012b) were used throughout this study. For gametocyte production, asynchronous parasites were diluted to 0.8-1% parasitaemia and cultured for 15-17 days before mosquito infections.
Mosquito Rearing and Transgenesis
All mosquitoes were kept at 27-29 C and 70-80% humidity. A. coluzzii (Ngousso strain) mosquitoes were used for the production of Pf NF54 sporozoites for traversal and IFA assays. A. coluzzii (Ngousso strain) XK docking line was used for transgenesis (Volohonsky et al., 2015) . A. stephensi mosquitoes were used for experiments with humanized FRG-huHep mice (see also Figure 3E ) and for the phenotypic analysis of Pb-PfCSP parasites (see also Figures S6E and S6H) . A. gambiae 7b mosquitoes (Pompon and Levashina, 2015) , an immunocompromised transgenic mosquito line derived from the G3 laboratory strain, were used for the characterization and production of Pb-PfCSP sporozoites.
Mice
Female C57BL/6J mice (8-weeks old) were purchased from Charles River and handled in accordance with the German Animal Protection Law (x8 Tierschutzgesetz) and approved by the Landesamt f€ ur Gesundheit und Soziales (Lageso), Berlin, Germany (project numbers 411/08 and 0027/12). FRG-huHep mice were purchased from Yecuris, Inc. with a minimum serum human albumin concentration of 3 mg/ml, indicating robust human hepatocyte repopulation. See ''Key Resources Table' ' for details. Littermates were randomly assigned to experimental groups which were kept in separate cages.
METHOD DETAILS
Flow Cytometry and Single Cell Sorting Peripheral blood was obtained by venous puncture from participants positive for anti-CSP serum antibodies. For donor 71 we obtained and used a second blood sample that was collected two years later. Peripheral mononuclear cells (PBMCs) were isolated using Percoll gradient density centrifugation (GE Healthcare). NF54 Pf CSP (Protein Potential LLC) and MSP3 were chemically coupled to Alexa647 according to the manufacturer's protocol (Invitrogen). Protein concentrations were determined using Nanodrop (Thermo Scientific). CSP-reactive or MSP3-reactive memory B cells were analyzed on a LSR II instrument and isolated using an ARIA II cell sorter (BD Bioscience). Cells were stained using CSP-Alex647 (1:20; 0.6mg/ml) or MSP3-Alexa647 (1:20; 0.3mg/ml) and the following antibodies: mouse anti-human CD19-PeCy7 (1:20, eBioscience), mouse anti-human CD27-FITC (1:5, BD) and mouse anti-human IgG-Biotin (1:200, BD). Biotin was detected using Streptavidin Qdot 605 (1:800, Life Technologies). 7AAD (1:200, Invitrogen) was included in all stainings to exclude dead cells. The data were analyzed using FlowJo v10 software. + IgG -cells were later confirmed to be IgM + by sequence analysis. As all three cell populations were isolated based on CSP-reactivity and thus Ig surface expression, we define them as CSP-reactive memory B cells.
Ig Gene Cloning and Recombinant Antibodies
Ig gene cloning and recombinant antibody production were performed as described before (Tiller et al., 2008) . In brief, cDNA of each single cell was generated using random hexamer primers. Ig heavy and corresponding Ig kappa or Ig lambda L-chain gene transcripts were amplified using a semi-nested PCR strategy (Tiller et al., 2008) . Amplicons were Sanger sequenced and cloned into human Igg1 and Igk or Igl expression vectors, respectively (Tiller et al., 2008) . The corresponding heavy and light expression vector DNAs were co-transfected into HEK293T cells (Invitrogen) and the recombinant antibodies were purified from supernatants using Protein G beads (GE Healthcare). IgG concentrations were determined by ELISA.
To generate a humanized version of the antibody 2A10 to use as a positive control cells from a murine 2A10 hybridoma cell line (BEI Resources) were harvested and RNA was extracted according to the manufacturer's protocol (Macherey Nagel). cDNA was generated as described previously (Tiller et al., 2008) . Ig gene transcripts of the H-and kappa L-chain were amplified using the following primers: heavy forward primer mIghV-Y/AgeI-081-fw: 5'-CTGCAACCGGTGTACATTCCCAGATCCAGTTGGTACAGTCTGG-3', reverse primer mIghJ-D/SalI-034-rv: 5'-TGCGAAGTCGACGCTGAGGAGACGGTGACTGAGG-3', kappa forward primer mIgkV-P/ AgeI-084-fw: 5'-CTGCAACCGGTGTACATTCCGATATCCAGATGACACAGA CTACA-3' and kappa revers primer: mIgkJ-B/BsiWI-020-rv: 5'-GCCACCGTACGTTTTATTTCC AGCTTGGTC-3'. Gene transcripts were sequenced and cloned into the human Igg1 and Igk expression vectors. Antibody was then expressed and purified as described above.
Enzyme-Linked Immunosorbent Assay 96 well plates (Costar) were coated overnight at 4 C with 40 ng/well of N-terminally truncated Pf CSP (CSP) with the amino acids 123-411 (kind gift from Silvia Boscardin) (Tewari et al., 2010) , 100 ng/well NANP 10 -repeat (Alpha Diagnostic Intl Inc.), 10 mg/ml insulin (Sigma Aldrich) or 5 mg/ml LPS (Sigma Aldrich) solution in PBS. ELISA plates were blocked for 1 h with 4% BSA in PBS (serum ELISA), 1% BSA in PBS (antigen ELISA) or blocking buffer (1x PBS, 0.05% (v/v) Tween20, 1 mM EDTA) (IgG concentration ELISA). Coated plates were incubated with the serum or recombinant monoclonal antibodies at the indicated concentrations for 1 h at RT. Bound antibodies were detected by goat anti-human IgG or goat anti-human IgM secondary antibody coupled to horse-radish-peroxidase (HRP) (Jackson Immuno Research) diluted 1:1,000 in 1% BSA in PBS which was then detected using an ABTS substrate solution complimented with H 2 O 2 (Roche). The optical density (OD) at 405 nm was determined on an M1000Pro plate reader (Tecan). Graphs were created and area under curve (AUC) values were calculated using GraphPad Prism 6.07. 2A10 (Zavala et al., 1983 ) was used as a positive and mGO53 (Wardemann et al., 2003) as a negative control.
Generation of Chimeric Pb Parasites
To generate the chimeric parasites where the Pb csp coding sequence (CDS) (Pbcsp; PBANKA_0403200) has been replaced by the Pf csp CDS (Pfcsp; PF3D7_0304600), we used a 2-step GIMO transfection protocol (Lin et al., 2011; Salman et al., 2015) and the transgenic p230p locus of the reporter Pb ANKA parasite line Pb ANKA-GFP-Luc eef1a (676m1cl1) (parental). The fusion protein of GFP and firefly luciferase (LUC-IAV) is expressed under the constitutive Pbeef1a promoter. The reporter-cassette is integrated into the neutral p230p locus in chromosome 3. In the first step we deleted the Pb csp CDS and replaced it with the positive-negative selectable marker, to create a Pb csp deletion GIMO line (PbANKA-DCSP GIMO). In order to do this, we generated a construct (pL1929) that is based on the standard GIMO DNA construct pL0034. This construct contains the positive-negative (hdhfr::yfcu) selection marker (SM) cassette, and was used to insert both the Pbcsp 5' and 3' gene targeting regions (TR), encompassing the full length promoter and transcription terminator sequences, respectively, and was transfected into the parental Pb ANKA-GFP-Luc eef1a parasites (676m1cl1) using standard methods of transfection (Janse et al., 2006) . The following primers were used:
Primers for the DNA Constructs for the Generation of the Chimeric Parasite Line
Transfected parasites were selected in mice by applying positive selection by providing pyrimethamine in the drinking water (Janse et al., 2006) . Transfected parasites were cloned by limiting dilution (Salman et al., 2015) , resulting in the PbANKA-DCSP GIMO line (line 2251cl1).
In the second step we replaced the positive-negative SM in the PbANKA-CSP GIMO genome with the Pf csp CDS by GIMO transfection to create the Pb chimeric CSP replacement line. This was achieved by modifying the construct used in the first step (pL1929); specifically, the hdfhr::yfcu SM cassette was removed and replaced with Pf csp CDS sequence, generating plasmid pL1972. The Pf csp CDS was amplified from genomic DNA of the Pf NF54 strain. The pL1972 construct was sequenced to ensure there were no mutations in the Pf csp CDS using the primers listed above. The constructs were linearized using ApaI and NotI restriction enzymes outside of the 5' and 3' TRs before transfection. The construct was used to transfect parasites of the PbANKA-CSP GIMO line (line 2251cl1) using standard methods of GIMO-transfection (Lin et al., 2011) . Transfected parasites were selected in mice by applying negative selection by providing 5-fluorocytosine (5-FC) in the drinking water of mice (Salman et al., 2015) . Negative selection results in selection of chimeric parasites where the hdhfr::yfcu SM in the csp locus of PbANKA-CSP GIMO line is replaced by the CDS of Pf csp. Selected chimeric parasites were cloned by the method of limiting dilution. Correct integration of the constructs into the genome of chimeric parasites was analyzed by diagnostic PCR-analysis on gDNA and Southern analysis of pulsed field gel separated chromosomes as described elsewhere (Janse et al., 2006) . Primers used for PCR genotyping are listed here:
Primers for Genotyping of the Chimeric Parasite Line
Mosquito Transgenesis
The transgenesis construct contained a reporter cassette with a gene encoding DsRed2 under the control of a nervous system-specific 3xPax3 promoter and SV40 terminator. The single-chain antibody (scFv) sequence was designed by linking the variable regions of the H-and L-chain of monoclonal antibody 125 by a glycine-rich linker (GGGGSGGGGSGGGGS). The Anopheline salivary glandspecific anti-platelet protein gene (Aapp) signal peptide was identified by SignalP 4.1 Server (http://www.cbs.dtu.dk/services/ SignalP/) and Signal Blast programs (http://sigpep.services.came.sbg.ac.at/signalblast.html) and fused to the N-terminus of the scFv 125 sequence (sc125), whereas the Flag tag (DYKDDDDK) was fused to the C-terminus. The sequences were codon-optimized with the GENEius online tool using A. gambiae codon preference table (Volohonsky et al., 2015) , synthesized and sequenced (Eurofins). The anti-CSP scFv125 single-chain antibody gene was placed between the promoter of Aapp (AGAP009974) (Yoshida and Watanabe, 2006) and the SV40 terminator. Transgenes were assembled into pDSAR vectors and insertion into the XK docking line in the mosquito genome was mediated by 4C31 integrase (Volohonsky et al., 2015) . Because of the homozygous lethality of the insertion, each generation of dsRed2-positive Aapp::125 heterozygous females was purified by COPAS sorting (Union Biometrica) and back-crossed with wild-type males (Ngousso strain). Expression of the transgene at transcript and protein level was confirmed by quantitative Real-Time-PCR and by immunoblotting using the anti-FLAG antibody, respectively (see also Supplemental Figures S3C and S3D ).
In Vivo Plasmodium Infections Female C57BL/6 mice were passively immunized (4-6 per group) by i.p. injection of 400 mg monoclonal antibody in 100 ml of PBS. One day later, Pb-PfCSP sporozoites (5*10 3 ) were injected s.c. into the mouse tail. For bite-back experiments, mice were exposed to the bites of wild-type or Aapp::125 transgenic mosquitoes 18-19 days post Pb-PfCSP infection (range 1-9 infectious bites per mouse). Blood parasitaemia was assayed by daily tests of Giemsa-stained thin blood smears and a minimum of 100 microscopic fields were counted. After onset of parasitaemia, mice were monitored every 6-12 h for severe neurological and behavioral symptoms typical of experimental cerebral malaria (ECM) defined as hunched body position, grooming alteration, ataxia, paralysis, or convulsions (Lackner et al. Passive antibody transfer and challenge experiments with PfGFP-luc sporozoites using FRG-huHep mice were performed as previously published (Ishizuka et al., 2016) (Sack et al., 2017) . Hepatocyte donor-matched mice were administered i.p 150 mg/mouse of monoclonal antibody in 200 ml of PBS the day before challenge. Mice were infected by exposing them to mosquitoes (n=50, 50% infection rate with an average of >10 oocysts/mosquito). Parasite liver burden was assessed as previously published (Ishizuka et al., 2016) using an IVIS imaging system and LivingImage software. To determine ''% of control'' parasite liver burden, the average total flux (photons/second) of all control mice was averaged and the ''% of control'' for each mouse was calculated as a percentage of this value. Results are expressed as a percentage of the average parasite liver burden of mice given control monoclonal antibody mGO53 (Wardemann et al., 2003) .
Immunofluorescence Assay
Pf NF54, Pb-PfCSP or Pb parental salivary gland sporozoites (4*10 4 /well) were air-dried overnight on 8-well microscopy slides (Medco) pre-coated with 3% BSA in RPMI. After fixation with 4% paraformaldehyde (PFA, Alfa Alsar), sporozoites were blocked with 10% FCS/PBS and then incubated for 45 min at 37 C or 1-2 h at RT in duplicates with 20-25 ml of serum or monoclonal antibodies (100 mg/ml) diluted in 10% FCS/PBS. The monoclonal antibody 2A10 was used as a positive control for Pf (Zavala et al., 1983) and Pb-PfCSP and 3D11 (Yoshida et al., 1980) for Pb sporozoites. Bound antibodies were revealed by incubation for 45 min at 37 C or 1h at RT with a Cy3-conjugated goat anti-human-IgG (diluted 1:1,000; Jackson Immuno Research) or an Alexa Fluor Ò 488 goat anti-mouse IgG (diluted 1:1,000; Life Technologies), respectively. Images were acquired on an AxioObserver Z1 fluorescence microscope equipped with an Apotome module (Zeiss) using the 63x objective or a DMI-300B Leica fluorescence microscope. Images were analyzed using the AxioVision ZEN 2012 software (Zeiss) and ImageJ (Rasband, 1997 (Rasband, -2015 .
Sporozoite Hepatocyte Traversal Assay
Traversal assays were performed as described elsewhere (Behet et al., 2014) . Briefly, 6*10 4 cells/well of a human hepatocyte cell line (HC-04, MRA-975, deposited by Jetsumon Sattabongkot) were seeded into a 96-well plate (Greiner, TPP and Costar) and incubated for 24 h at 5% CO 2 and 37 C (70% confluency). Isolated Pf salivary gland sporozoites (10 5 ) were pre-incubated with 100 mg/ml monoclonal antibodies in 50 ml for 30 min on ice. 5*10 4 sporozoites per well were then seeded in duplicates onto HC-04 cells in presence of 0.5 mg/ml dextran-rhodamine (Molecular Probes) and a final antibody concentration of 50 mg/ml. As a negative control sporozoites pre-treated for 5 min on ice with the actin polymerization inhibitor Cytochalasin D (1.25 mg/ml, Sigma Aldrich) were used. Non-treated sporozoites were used as a positive control and non-infected cells incubated with dextran-rhodamine were used as background control. The plates were centrifuged for 10 min at 3,000 rpm at RT without brakes. After 2 h, cells were trypsinized and fixed in 1% PFA in PBS. Dextran-rhodamine positive cells were quantified by flow cytometry (LSR II, BD Biosciences). Sporozoite cell traversal rates were determined after correction for background dextran incorporation in non-infected cells. Sporozoite traversal of untreated sporozoites was set as 0% traversal inhibition.
Exoerythrocytic Forms Developmental Assay HC-04 cells (10 4 /well) were seeded into a rat collagen (BD Biosciences) pre-treated 96-well plate with transparent bottom (Nalgene International). Pb-PfCSP salivary gland sporozoites (10 4 ) were pre-incubated for 30 min on ice with or without 50 mg/ml (antibody 125 in Extended Data Fig. 5e ) or 100 mg/ml monoclonal antibodies. Pb-PfCSP sporozoites were then added to the cells in triplicates and the plate was centrifuged at 110xg for 1 min at RT. After 2 h of incubation extracellular sporozoites were removed by three washes with 2% combined penicillin and streptomycin solution with 5 mg/ml fungizone and one time without fungizone. Two days later, the cells were fixed with 4% PFA for 15 min at RT before permeabilization with 50 mM NH 4 Cl 2 (Sigma Aldrich), 3% FBS, 0.3% Triton (Sigma Aldrich) for 1 h at 37 C. Development of exoerythrocytic forms (EEFs) was examined using rabbit anti-GFP antibody (1:1,000; Abcam) diluted in permeabilization buffer for 1 h at 37 C and AlexaFluor Ò 555 conjugated anti-rabbit-IgG antibody (1:1,000; Molecular Probes). Nuclei were stained with DAPI (1.25 mg/ml, Molecular Probes). Images were acquired in the 96 well plates on an AxioObserver Z1 fluorescence microscope equipped with an Apotome module (Zeiss, 10x objective). EEF numbers were counted using the AxioVision ZEN 2012 software (Zeiss). EEF development of untreated sporozoites was set as 0% of EEF inhibition.
Quantitative Real-Time (RT)-PCR Aapp::125 transcripts were examined by quantitative RT-PCR in the thoracic and abdominal segments of the transgenic mosquitoes. Total RNA was extracted from thoraxes and abdomens of 15 mosquitoes with TriReagent (Sigma Aldrich) according to the manufacturer's protocol. Total RNA (2 mg) was converted into cDNA using the RevertAid H Minus Reverse Transcriptase kit (Fermentas) and random hexamers (Fermentas). Quantitative PCR reactions were run on a StepOnePlusÔ RT-PCR instrument (Applied Biosystems) using the Fast SYBR Ò Green Master mix (Applied Biosystems) according to the manufacturer's protocol. Specific primers amplified a 66 nt fragment connecting the signal peptide and the scFv (VB739: 5'-GAAGTTTCTACTGCTTGTGGCTAGTGT-3' and VB740: 5'-AGCTGGATCTGGGCGGATA-3').
Immunoblotting
Transgenic Aapp::125 mosquitoes were cut with micro-scissors (World Precision Instruments) along the abdomen-thorax junction. Thoraxes and abdomens of 15 mosquitoes were ground in 50 mM Tris HCl, 150 mM NaCl, 1% Triton, 0.1% SDS (Sigma Aldrich) in the Biolayer Interferometry Binding Studies BLI (Octet RED96, ForteBio) experiments were conducted to determine the specificity and binding kinetics of 580-g-Fab, 580-Fab, 663-g-Fab and 663-Fab for Pf CSP (7G8 strain). Pf CSP was diluted to 10 mg/ml in kinetics buffer (PBS, pH 7.4, 0.01% (w/v) BSA, 0.002% Tween20) and immobilized onto Ni-NTA (NTA) biosensors (Forté Bio). Following establishment of a stable baseline with loaded ligand in kinetics buffer, biosensors were dipped into wells containing 2-fold dilution series of Fab. Tips were then dipped back into kinetics buffer to monitor the dissociation rate. Kinetics data were analyzed using Forté Bio's Data Analysis software 9.0, and curves were fitted to a 1:1 binding model.
Crystallization and Structure Determination
Purified 580-g-Fab and 663-Fab were concentrated to 12 mg/ml and diluted to 10 mg/ml with NANP 5 (10 mg/ml) in a 1:5 molar ratio prior to crystallization trials. Crystals for 580-g-Fab-NANP 5 grew in 10% (v/v) isopropanol, 100 mM HEPES pH 7. Data were collected at the 08ID-1 beamline at the Canadian Light Source (CLS), processed and scaled using XDS (Kabsch, 2010) . The structures were determined by molecular replacement using Phaser (McCoy et al., 2007) . Refinement of the structures was carried out using phenix.refine (Adams et al., 2010) and iterations of refinement using Coot (Emsley et al., 2010) . All software was accessed through SBGrid (Morin et al., 2013) .
SAXS Data Collection and Processing
SAXS data were collected at the BioSAXS 18-ID-D beamline at the Argonne Photon Source. 580-Fab and 663-Fab were co-complexed with Pf CSP (7G8 strain) in a 1.7:1 molar ratio of Fab to Pf CSP. Data on Pf CSP alone was also collected. Samples were applied to an in-line SEC-SAXS instrument at a flow rate of 0.7 ml/min, and images were collected after 1s exposure. Buffer control samples were derived from regions in the SEC-SAXS profile preceding elution of the sample and were used to correct the scattering curves. Approximately 10 frames from the SEC peak were averaged to generate an idealized scattering curve using PRIMUS (Figure S5A ) (Konarev et al., 2003) . The Kratky and Guinier plots were inspected to assess the presence of unfolding, aggregation or radiation damage ( Figure S5C ). The radius of gyration was determined from the Guinier plot using AutoRg (Konarev et al., 2003) . The distance distribution function P(r) was obtained by indirect Fourier transform, which generated an estimate of the D max and the Porod volume ( Figure S5D ). The apparent molecular weight was estimated by dividing the Porod volume by 1.7. Twenty ab initio models were generated using DAMMIF (Franke and Svergun, 2009) and averaged using DAMAVER . Chimera was used to visualize and dock the atomic structures into the SAXS envelopes.
Surface Plasmon Resonance SPR measurements were performed with a BIACORE T200 (GE Healthcare) instrument docked with a series S sensor chip CM5 (GE Healthcare). Anti-human IgG antibodies in 10 mM HEPES with 150 mM NaCl at pH 7.4 (running buffer) were immobilized by aminecoupling using a human antibody capture kit (GE Healthcare) following the manufacturer's protocol. Equal concentrations of the sample and control antibody mGO53 (Wardemann et al., 2003) were captured in the sample and reference flow cell, respectively. After stabilizing the flow cells with running buffer at 10 ml/min flow rate for 20 min, NANP 5 dissolved in running buffer was injected at different concentrations: 0, 0.015, 0.09, 0.55, 3.3 and 20 mM. Maintaining the flow rate of 30 ml/min allowed the association and dissociation of NANP 5 for 60s and 180s, respectively, at 25 C. Regeneration of both flow cells with 3 M MgCl 2 was conducted after each run. The data were fit using a 1:1 binding model or steady state kinetic analysis using the BIACORE T200 softwareV2.0.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics were performed using R version 0.99.484 and GraphPad Prism 6.07. Normality of distribution was tested for all quantitative data sets by the Shapiro-Wilk test. Parametric or non-parametric tests were applied accordingly and are stated in the figure legends. P values < 0.05 were considered significant (****: p<0.0001, **: p<0.001) and indicated in the figures. Mantel-Cox test was used for comparison of mice survival. Plots were produced using GraphPad Prism 6.07, Adobe Illustrator CS6 v16.0.3, ImageJ (Rasband, 1997 (Rasband, -2015 and R version 0.99.484 using the ggplot2 package (R Development Core Team, 2008) .
DATA AND SOFTWARE AVAILABILITY
The data that support the findings of this report are available from the corresponding authors upon reasonable request. The crystal structures reported in this manuscript have been deposited in the Protein Data Bank, www.rcsb.org (PDB ID codes 6AZM, 5BK0, 5BK3, 5BK5 and 6AZX).
